The ‘Brussels 4’: essential requirements for implantable brain-computer interface user autonomy

Thomas J. Oxley; Darrel R. Deo; Stephanie Cernera; Abbey Sawyer; David Putrino; Nick F. Ramsey; Adam Fry

doi:10.1088/1741-2552/ada0e6

The ‘Brussels 4’: essential requirements for implantable brain-computer interface user autonomy

Thomas J. Oxley, Darrel R. Deo, Stephanie Cernera, Abbey Sawyer, David Putrino, Nick F. Ramsey, Adam Fry

Research output: Contribution to journal › Article › peer-review

Abstract

Objective. Implantable brain-computer interfaces (iBCIs) hold great promise for individuals with severe paralysis and are advancing toward commercialization. The features required for successful clinical translation and patient adoption of iBCIs may be under recognized within traditional academic iBCI research and deserve further consideration. Approach. Here we consider potentially critical factors to achieve iBCI user autonomy, reflecting the authors’ perspectives on discussions during various sessions and workshops across the 10th International BCI Society Meeting, Brussels, 2023. Main results. Four key considerations were identified: (1) immediate use, (2) easy to use, (3) continuous use, and (4) stable system use. Significance. Addressing these considerations may enable successful clinical translation of iBCIs.

Original language	English
Article number	013002
Journal	Journal of Neural Engineering
Volume	22
Issue number	1
DOIs	https://doi.org/10.1088/1741-2552/ada0e6
State	Published - 1 Feb 2025

Keywords

BCI
autonomy
clinical translation
commercialization
intracranial brain-computer interfaces
motor impairment
severe paralysis

Access to Document

10.1088/1741-2552/ada0e6

Cite this

@article{c7b5441a95db401284bc022ebf92a84f,

title = "The {\textquoteleft}Brussels 4{\textquoteright}: essential requirements for implantable brain-computer interface user autonomy",

abstract = "Objective. Implantable brain-computer interfaces (iBCIs) hold great promise for individuals with severe paralysis and are advancing toward commercialization. The features required for successful clinical translation and patient adoption of iBCIs may be under recognized within traditional academic iBCI research and deserve further consideration. Approach. Here we consider potentially critical factors to achieve iBCI user autonomy, reflecting the authors{\textquoteright} perspectives on discussions during various sessions and workshops across the 10th International BCI Society Meeting, Brussels, 2023. Main results. Four key considerations were identified: (1) immediate use, (2) easy to use, (3) continuous use, and (4) stable system use. Significance. Addressing these considerations may enable successful clinical translation of iBCIs.",

keywords = "BCI, autonomy, clinical translation, commercialization, intracranial brain-computer interfaces, motor impairment, severe paralysis",

author = "Oxley, {Thomas J.} and Deo, {Darrel R.} and Stephanie Cernera and Abbey Sawyer and David Putrino and Ramsey, {Nick F.} and Adam Fry",

note = "Publisher Copyright: {\textcopyright} 2025 The Author(s). Published by IOP Publishing Ltd.",

year = "2025",

month = feb,

day = "1",

doi = "10.1088/1741-2552/ada0e6",

language = "English",

volume = "22",

journal = "Journal of Neural Engineering",

issn = "1741-2560",

publisher = "IOP Publishing Ltd.",

number = "1",

}

TY - JOUR

T1 - The ‘Brussels 4’

T2 - essential requirements for implantable brain-computer interface user autonomy

AU - Oxley, Thomas J.

AU - Deo, Darrel R.

AU - Cernera, Stephanie

AU - Sawyer, Abbey

AU - Putrino, David

AU - Ramsey, Nick F.

AU - Fry, Adam

PY - 2025/2/1

Y1 - 2025/2/1

N2 - Objective. Implantable brain-computer interfaces (iBCIs) hold great promise for individuals with severe paralysis and are advancing toward commercialization. The features required for successful clinical translation and patient adoption of iBCIs may be under recognized within traditional academic iBCI research and deserve further consideration. Approach. Here we consider potentially critical factors to achieve iBCI user autonomy, reflecting the authors’ perspectives on discussions during various sessions and workshops across the 10th International BCI Society Meeting, Brussels, 2023. Main results. Four key considerations were identified: (1) immediate use, (2) easy to use, (3) continuous use, and (4) stable system use. Significance. Addressing these considerations may enable successful clinical translation of iBCIs.

AB - Objective. Implantable brain-computer interfaces (iBCIs) hold great promise for individuals with severe paralysis and are advancing toward commercialization. The features required for successful clinical translation and patient adoption of iBCIs may be under recognized within traditional academic iBCI research and deserve further consideration. Approach. Here we consider potentially critical factors to achieve iBCI user autonomy, reflecting the authors’ perspectives on discussions during various sessions and workshops across the 10th International BCI Society Meeting, Brussels, 2023. Main results. Four key considerations were identified: (1) immediate use, (2) easy to use, (3) continuous use, and (4) stable system use. Significance. Addressing these considerations may enable successful clinical translation of iBCIs.

KW - BCI

KW - autonomy

KW - clinical translation

KW - commercialization

KW - intracranial brain-computer interfaces

KW - motor impairment

KW - severe paralysis

UR - http://www.scopus.com/inward/record.url?scp=85217449340&partnerID=8YFLogxK

U2 - 10.1088/1741-2552/ada0e6

DO - 10.1088/1741-2552/ada0e6

M3 - Article

C2 - 39693762

AN - SCOPUS:85217449340

SN - 1741-2560

VL - 22

JO - Journal of Neural Engineering

JF - Journal of Neural Engineering

IS - 1

M1 - 013002

ER -

The ‘Brussels 4’: essential requirements for implantable brain-computer interface user autonomy

Abstract

Keywords

Access to Document

Fingerprint

Cite this